Search

everythinglearnresearchcommunity

for

Search:↓

Different types of hair loss are linked to COVID-19, with some types possibly increasing risk of getting the virus, while others may be triggered or worsened by the virus.

Alopecia areata, a common autoimmune hair loss condition, often runs in families.

Phototherapy can improve various types of hair loss with minimal side effects, but more research is needed to optimize treatment.

Hair follicles are key to treating vitiligo and alopecia areata, but challenges exist.

Hair follicles may help teach the immune system to tolerate new self-antigens, but this can sometimes cause hair loss.

Valproic acid can cause a skin condition called leukocytoclastic vasculitis, which usually gets better after stopping the drug.

Radiation therapy damages skin structure and immune function, causing inflammation and potential hair loss.

Mesenchymal stem cells may help treat hair loss by improving hair cell growth and reducing inflammation.

T-cell reconstitution after thymus transplantation can cause hair whitening and loss.

Macrophages are crucial for hair regrowth in contact hypersensitivity.

Activating mitophagy may help manage a key immune response involved in the hair loss condition alopecia areata.

Stress may contribute to hair loss in alopecia areata by affecting immune responses and cell death in hair follicles.

Denosumab, a bone loss treatment, may cause hair loss and skin reactions due to immune system effects.

COVID-19 recovery can lead to temporary hair loss called telogen effluvium.

Blocking certain immune signals can reduce skin damage from radiation therapy.

Aging skin is affected by inflammation, reduced stem cell function, and slower wound healing.

Stress-related substance P may lead to hair loss and negatively affect hair growth.

Human dermal γδT-cells respond to stress in hair follicles, contributing to hair loss.

Blocking certain pathways with kinase inhibitors may help treat cutaneous lupus erythematosus.

Stem cell transplantation shows promise for treating diseases but faces challenges like safety, ethics, and cost.

Advanced human skin models improve drug development and could replace animal testing.

Some drugs used to treat immune conditions may cause different types of hair loss.

Permanent hair loss after a stem cell transplant can be a sign of chronic immune system attack on the scalp.

The paper concludes that the patchiness of alopecia areata is likely due to when the immune attack happens in the hair growth cycle.

Certain medications, including some immune drugs, contraceptives, and hair loss treatments, are often linked to hair loss.

Squaric acid dibutylester helps hair growth by increasing certain immune cells in the skin.

Cholesterol-related compounds can stop hair growth and cause inflammation in a type of scarring hair loss.

Cancer patients treated with immune checkpoint inhibitors may develop alopecia, but some hair regrowth is possible with treatment.

Stopping Cyclosporine A led to hair regrowth in a child with alopecia.

Mogamulizumab can cause hair loss, often linked to a better treatment response.